Arie Perry, MD
Professor
Pathology
School of Medicine

In order to achieve this goal, my lab has applied immunohistochemical, molecular cytogenetic, and genomic screening techniques primarily towards the study of gliomas, meningiomas, and primitive pediatric malignancies. I have been particularly interested in improved classification and grading schemes as well as the identification of molecular genetic markers associated with tumorigenesis, malignant progression, and/or biologic behavior. I collaborate with a number of clinical and scientific researchers both within and outside UCSF and it is our hope that the markers we identify will improve patient management and lead to the development of novel therapeutic approaches. I also maintain a private consultation service for difficult surgical neuropathology cases obtained from the U.S. and abroad, particularly brain tumors.

• Epigenetic reprogramming shapes the cellular landscape of schwannoma.
  Nature communications 2024 Liu SJ, Casey-Clyde T, Cho NW, Swinderman J, Pekmezci M, Dougherty MC, Foster K, Chen WC, Villanueva-Meyer JE, Swaney DL, Vasudevan HN, Choudhury A, Pak J, Breshears JD, Lang UE, Eaton CD, Hiam-Galvez…
• Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.
  Nature communications 2024 Vasudevan HN, Payne E, Delley CL, John Liu S, Mirchia K, Sale MJ, Lastella S, Nunez MS, Lucas CG, Eaton CD, Casey-Clyde T, Magill ST, Chen WC, Braunstein SE, Perry A, Jacques L, Reddy AT, Pekmezci M, …
• Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group.
  Neuro-oncology 2023 Mueller S, Fangusaro J, Thomas AO, Jacques TS, Bandopadhayay P, de Blank P, Packer RJ, Fouladi M, van Meeteren AS, Jones D, Perry A, Nakano Y, Hargrave D, Riedl D, Robinson NJ, Partanen M, Fisher MJ, …
• "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
  Acta neuropathologica 2023 Hadad S, Gupta R, Oberheim Bush NA, Taylor JW, Villanueva-Meyer JE, Young JS, Wu J, Ravindranathan A, Zhang Y, Warrier G, McCoy L, Shai A, Pekmezci M, Perry A, Bollen AW, Phillips JJ, Braunstein SE, …
• Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs.
  Neuro-oncology 2023 Williams EA, Ravindranathan A, Gupta R, Stevers NO, Suwala AK, Hong C, Kim S, Yuan JB, Wu J, Barreto J, Lucas CG, Chan E, Pekmezci M, LeBoit PE, Mully T, Perry A, Bollen A, Van Ziffle J, Devine WP, …
• Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
  Nature medicine 2023 Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci AO, Klisch TJ, Nguyen MP, Vasudevan HN, McCortney K, Yu TJ, Bhave V, …
• Cavernous sinus hemangioma: Histopathological spectrum of 8 cases.
  Journal of neuropathology and experimental neurology 2023 Rasband JM, Alfattal R, Patel AJ, Fuller GN, Perry A, Lu HC
• Meningeal solitary fibrous tumor cell states phenocopy cerebral vascular development and homeostasis.
  Research square 2023 Raleigh D, Mirchia K, Choudhury A, Joseph T, Birrueta J, Phillips J, Bhaduri A, Crouch E, Perry A
• Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS.
  Blood advances 2023 Guney E, Lucas CG, Singh K, Pekmezci M, Fernandez-Pol S, Mirchia K, Toland A, Vogel H, Bannykh S, Schafernak KT, Alexandrescu S, Mobley BC, Powell S, Davidson CJ, Neltner J, Boué DR, Hattab E, Ferris …
• NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy.
  bioRxiv : the preprint server for biology 2023 Choudhury A, Cady MA, Lucas CG, Najem H, Phillips JJ, Palikuqi B, Zakimi N, Joseph T, Birrueta JO, Chen WC, Bush NAO, Hervey-Jumper SL, Klein OD, Toedebusch CM, Horbinski CM, Magill ST, Bhaduri A, …
• Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
  Endocrine pathology 2023 Asa SL, Mete O, Riddle ND, Perry A
• Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution.
  Research square 2023 Lucas CH, Mirchia K, Seo K, Najem H, Chen W, Zakimi N, Choudhury A, Liu SJ, Phillips J, Magill S, Horbinski C, Solomon D, Perry A, Vasudevan H, Heimberger A, Raleigh D
• Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
  Acta neuropathologica 2023 Keck MK, Sill M, Wittmann A, Joshi P, Stichel D, Beck P, Okonechnikow K, Sievers P, Wefers AK, Roncaroli F, Avula S, McCabe MG, Hayden JT, Wesseling P, Øra I, Nistér M, Kranendonk MEG, Tops BBJ, …
• Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
  Research square 2023 Raleigh D, Chen W, Choudhury A, Youngblood M, Polley MY, Lucas CH, Mirchia K, Maas S, Suwala A, Won M, Bayley J, Harmanci A, Harmanci A, Klisch T, Nguyen M, Vasudevan H, McCortney K, Yu T, Bhave V, …
• Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features.
  Neuro-oncology 2023 Choudhury A, Chen WC, Lucas CG, Bayley JC, Harmanci AS, Maas SLN, Santagata S, Klisch T, Perry A, Bi WL, Sahm F, Patel AJ, Magill ST, Raleigh DR
• Sarcomatous Transformation of a Medically Treated Lactotroph Pituitary Neuroendocrine Tumor?
  Endocrine pathology 2023 Terry M, Reis G, Horvai A, Pekmezci M, Perry A
• Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.
  Acta neuropathologica 2023 Tang V, Lu R, Mirchia K, Van Ziffle J, Devine P, Lee J, Phillips JJ, Perry A, Raleigh DR, Lucas CG, Solomon DA
• Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.
  Neuro-oncology 2023 Rogers CL, Pugh SL, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Barani IJ, Braunstein S, Bovi JA, de Groot JF, Whitton AC, Lindhorst SM, Deb N, Shrieve DC, Shu HK, Bloom B, Machtay M, Mishra…
• Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin.
  The American journal of surgical pathology 2022 Asa SL, Mete O, Schüller U, Ramani B, Mirchia K, Perry A
• Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
  Acta neuropathologica 2022 Keck MK, Sill M, Wittmann A, Joshi P, Stichel D, Beck P, Okonechnikow K, Sievers P, Wefers AK, Roncaroli F, Avula S, McCabe MG, Hayden JT, Wesseling P, Øra I, Nistér M, Kranendonk MEG, Tops BBJ, …
• Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.
  Acta neuropathologica 2022 Wu Z, Rajan S, Chung HJ, Raffeld M, Panneer Selvam P, Schweizer L, Perry A, Samuel D, Giannini C, Ragunathan A, Frosch MP, Marshall MS, Boué DR, Donev K, Neill SG, Fernandes I, Resnick A, Rood B, …
• Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes.
  Neuro-oncology 2022 Zhang Y, Lucas CG, Young JS, Morshed RA, McCoy L, Oberheim Bush NA, Taylor JW, Daras M, Butowski NA, Villanueva-Meyer JE, Cha S, Wrensch M, Wiencke JK, Lee JC, Pekmezci M, Phillips JJ, Perry A, Bollen…
• Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.
  Acta neuropathologica 2022 Lucas CG, Sloan EA, Gupta R, Wu J, Pratt D, Vasudevan HN, Ravindranathan A, Barreto J, Williams EA, Shai A, Whipple NS, Bruggers CS, Maher O, Nabors B, Rodriguez M, Samuel D, Brown M, Carmichael J, Lu…
• Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma.
  Journal of neuropathology and experimental neurology 2022 Lucas CG, Davidson CJ, Alashari M, Putnam AR, Whipple NS, Bruggers CS, Mendez JS, Cheshier SH, Walker JB, Ramani B, Cadwell CR, Sullivan DV, Lu R, Mirchia K, Van Ziffle J, Devine P, Goldschmidt E, …
• CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Kumar A, Mohamed E, Tong S, Chen K, Mukherjee J, Lim Y, Wong CM, Boosalis Z, Shai A, Pieper RO, Gupta N, Perry A, Bollen AW, Molinaro AM, Solomon DA, Shieh JTC, Phillips JJ
• Intratumor and informatic heterogeneity influence meningioma molecular classification.
  Acta neuropathologica 2022 Vasudevan HN, Choudhury A, Hilz S, Villanueva-Meyer JE, Chen WC, Lucas CG, Braunstein SE, Oberheim Bush NA, Butowski N, Pekmezci M, McDermott MW, Perry A, Solomon DA, Magill ST, Raleigh DR
• Immature PIT1-Lineage Pituitary Neuroendocrine Tumor: a 17-Year-Old Male with Pathogenic AIP Mutation.
  Endocrine pathology 2022 Lu R, Pu C, Pekmeczi M, Perry A
• Molecular characterization of metachronous atypical teratoid rhabdoid tumors occurring in a young man 15 years apart.
  Pediatric blood & cancer 2022 Bruggers CS, Linscott L, Lee JC, Perry A, Klonoski J, Viskochil D, Cheshier S, Afify Z
• A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome.
  Blood advances 2022 Güney E, Lucas CG, Qi Z, Yu J, Zhang R, Ohgami RS, Rubenstein JL, Boué DR, Schafernak K, Wertheim GB, Dahiya S, Giulino-Roth L, Attarbaschi A, Barth MJ, Kothari S, Abla O, Cohen AL, Mendez JS, Bollen …
• Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.
  Nature genetics 2022 Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Cady MA, Seo K, Lucas CG, Casey-Clyde TJ, Vasudevan HN, Liu SJ, Villanueva-Meyer JE, Lam TC, Pu JK, Li LF, Leung GK, Swaney DL, Zhang MY, Chan JW,…
• Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas.
  Archives of pathology & laboratory medicine 2022 Brat DJ, Aldape K, Bridge JA, Canoll P, Colman H, Hameed MR, Harris BT, Hattab EM, Huse JT, Jenkins RB, Lopez-Terrada DH, McDonald WC, Rodriguez FJ, Souter LH, Colasacco C, Thomas NE, Yount MH, van …
• Overview of the 2022 WHO Classification of Pituitary Tumors.
  Endocrine pathology 2022 Asa SL, Mete O, Perry A, Osamura RY
• Molecular neuropathology of brain-invasive meningiomas.
  Brain pathology (Zurich, Switzerland) 2022 von Spreckelsen N, Kesseler C, Brokinkel B, Goldbrunner R, Perry A, Mawrin C
• High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13.
  Acta neuropathologica 2022 Pratt D, Abdullaev Z, Papanicolau-Sengos A, Ketchum C, Panneer Selvam P, Chung HJ, Lee I, Raffeld M, Gilbert MR, Armstrong TS, Pytel P, Borys E, Klonoski JM, McCord M, Horbinski C, Brat D, Perry A, …
• NTRK3 gene fusion in an adult ganglioglioma: illustrative case.
  Journal of neurosurgery. Case lessons 2022 Rubino S, Lynes J, McBride P, Sahebjam S, Mokhtari S, Farinhas JM, Perry A, Macaulay R, Vogelbaum MA
• Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma.
  Acta neuropathologica 2021 Lucas CG, Abdullaev Z, Bruggers CS, Mirchia K, Whipple NS, Alashari MM, Lowichik A, Cheshier S, Phillips JJ, Devine P, Solomon DA, Quezado M, Aldape KD, Perry A
• EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma.
  Acta neuropathologica 2021 Lucas CG, Gupta R, Wu J, Shah K, Ravindranathan A, Barreto J, Gener M, Ginn KF, Prall OWJ, Xu H, Kee D, Ko HS, Yaqoob N, Zia N, Florez A, Cha S, Perry A, Clarke JL, Chang SM, Berger MS, Solomon DA
• Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas.
  Brain pathology (Zurich, Switzerland) 2021 Sloan EA, Gupta R, Koelsche C, Chiang J, Villanueva-Meyer JE, Alexandrescu S, Eschbacher JM, Wang W, Mafra M, Ud Din N, Carr-Boyd E, Watson M, Punsoni M, Oviedo A, Gilani A, Kleinschmidt-DeMasters BK,…
• Orbital Rosai-Dorfman Disease Presenting as Optic Neuritis.
  Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2021 Virk HS, Shahlaie K, Ramani B, Perry A, Fragoso R, Tuscano J, Liu YA
• Diffuse hemispheric glioma, H3 G34-mutant: Genomic landscape of a new tumor entity and prospects for targeted therapy.
  Neuro-oncology 2021 Lucas CG, Mueller S, Reddy A, Taylor JW, Oberheim Bush NA, Clarke JL, Chang SM, Gupta N, Berger MS, Perry A, Phillips JJ, Solomon DA
• Genetic and epigenetic characterization of posterior pituitary tumors.
  Acta neuropathologica 2021 Schmid S, Solomon DA, Perez E, Thieme A, Kleinschmidt-DeMasters BK, Giannini C, Reinhardt A, Asa SL, Mete O, Stichel D, Siewert C, Dittmayer C, Hasselblatt M, Paulus W, Nagel C, Harter PN, …
• Adjuvant Maintenance Larotrectinib Therapy in 2 Children With NTRK Fusion-positive High-grade Cancers.
  Journal of pediatric hematology/oncology 2021 Carter-Febres M, Schneller N, Fair D, Solomon D, Perry A, Roy A, Linscott L, Alashari M, Kestle JR, Bruggers CS
• Tumor DNA requirements for accurate epigenetic-based classification of CNS neoplasia.
  Neuro-oncology 2021 Wu J, Gupta R, Barreto J, Doo P, Joseph NM, Lee JC, Perry A, Chang SM, Berger MS, Solomon DA
• The Multifaceted Appearance of Supratentorial Ependymoma with ZFTA-MAML2 Fusion.
  Free neuropathology 2021 Oon ML, Hendriansyah L, Pratiseyo PD, Wahjoepramono E, Goh JY, Kuick CH, Chang KT, Perry A, Tan CL
• Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing.
  Journal of neuropathology and experimental neurology 2021 Lucas CG, Devine P, Solomon DA, Giannini C, Reifenberger G, Dahiya S, Caccamo D, Perry A
• Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas.
  Acta neuropathologica 2021 Kirches E, Sahm F, Korshunov A, Bluecher C, Waldt N, Kropf S, Schrimpf D, Sievers P, Stichel D, Schüller U, Schittenhelm J, Riemenschneider MJ, Karajannis MA, Perry A, Pietsch T, Boekhoff S, Capper D,…
• The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
  Neuro-oncology 2021 Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW
• Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to 'Polymorphous low-grade neuroepithelial tumor of the young'.
  Acta neuropathologica 2021 Gupta R, Lucas CG, Wu J, Barreto J, Shah K, Simon IB, Casavilca-Zambrano S, Brathwaite C, Zhou H, Caccamo D, Gilani A, Kleinschmidt-DeMasters BK, Lee JC, Perry A, Clarke JL, Chang SM, Berger MS, …
• Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2021 Asa SL, Mete O, Cusimano MD, McCutcheon IE, Perry A, Yamada S, Nishioka H, Casar-Borota O, Uccella S, La Rosa S, Grossman AB, Ezzat S, Attendees of the 15th Meeting of the International Pituitary …
• The definition and role of brain invasion in meningioma grading: Still controversial after all these years.
  Free neuropathology 2021 Perry A
• The Pangenomic Classification of Pituitary Neuroendocrine Tumors: Quality Histopathology is Required for Accurate Translational Research.
  Endocrine pathology 2021 Mete O, Ezzat S, Perry A, Yamada S, Uccella S, Grossman AB, Asa SL
• A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR.
  Neuro-oncology 2021 Sievers P, Sill M, Schrimpf D, Stichel D, Reuss DE, Sturm D, Hench J, Frank S, Krskova L, Vicha A, Zapotocky M, Bison B, Castel D, Grill J, Debily MA, Harter PN, Snuderl M, Kramm CM, Reifenberger G, …
• Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms.
  Brain pathology (Zurich, Switzerland) 2021 Sloan EA, Chiang J, Villanueva-Meyer JE, Alexandrescu S, Eschbacher JM, Wang W, Mafra M, Ud Din N, Carr-Boyd E, Watson M, Punsoni M, Oviedo A, Gilani A, Kleinschmidt-DeMasters BK, Coss DJ, Lopes MB, …
• Eye-sparing Treatment of Localized Orbital Medulloepithelioma With Neoadjuvant Chemoradiation.
  Ophthalmic plastic and reconstructive surgery 2021 Gallo RA, Shoag J, Johnson TE, Solomon DA, Perry A, Podda A, Lee JY, Rong AJ
• A Prognostic Gene-Expression Signature and Risk Score for Meningioma Recurrence After Resection.
  Neurosurgery 2020 Chen WC, Vasudevan HN, Choudhury A, Pekmezci M, Lucas CG, Phillips J, Magill ST, Susko MS, Braunstein SE, Oberheim Bush NA, Boreta L, Nakamura JL, Villanueva-Meyer JE, Sneed PK, Perry A, McDermott MW,…
• Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1.
  Acta neuropathologica 2020 Sievers P, Sill M, Blume C, Tauziede-Espariat A, Schrimpf D, Stichel D, Reuss DE, Dogan H, Hartmann C, Mawrin C, Hasselblatt M, Stummer W, Schick U, Hench J, Frank S, Ketter R, Schweizer L, …
• Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults.
  Neuro-oncology advances 2020 Schulte JD, Buerki RA, Lapointe S, Molinaro AM, Zhang Y, Villanueva-Meyer JE, Perry A, Phillips JJ, Tihan T, Bollen AW, Pekmezci M, Butowski N, Oberheim Bush NA, Taylor JW, Chang SM, Theodosopoulos P,…
• Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival.
  Neuro-oncology advances 2020 Lucas CG, Vasudevan HN, Chen WC, Magill ST, Braunstein SE, Jacques L, Dahiya S, Rodriguez FJ, Horvai AE, Perry A, Pekmezci M, Raleigh DR
• The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma.
  Acta neuropathologica 2020 Ramani B, Gupta R, Wu J, Barreto J, Bollen AW, Tihan T, Mummaneni PV, Ames C, Clark A, Oberheim Bush NA, Butowski N, Phillips D, King BE, Bator SM, Treynor EC, Zherebitskiy V, Quinn PS, Walker JB, …
• Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
  Acta neuropathologica communications 2020 Lucas CG, Gupta R, Doo P, Lee JC, Cadwell CR, Ramani B, Hofmann JW, Sloan EA, Kleinschmidt-DeMasters BK, Lee HS, Wood MD, Grafe M, Born D, Vogel H, Salamat S, Puccetti D, Scharnhorst D, Samuel D, …
• Pediatric meningioma: a clinicopathologic and molecular study with potential grading implications.
  Brain pathology (Zurich, Switzerland) 2020 Toland A, McNulty SN, Pekmezci M, Evenson M, Huntoon K, Pierson CR, Boue DR, Perry A, Dahiya S
• Congenital tumors of the central nervous system: an institutional review of 64 cases with emphasis on tumors with unique histologic and molecular characteristics.
  Brain pathology (Zurich, Switzerland) 2020 Viaene AN, Pu C, Perry A, Li MM, Luo M, Santi M
• The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies.
  Cancer discovery 2020 Prager BC, Vasudevan HN, Dixit D, Bernatchez JA, Wu Q, Wallace LC, Bhargava S, Lee D, King BH, Morton AR, Gimple RC, Pekmezci M, Zhu Z, Siqueira-Neto JL, Wang X, Xie Q, Chen C, Barnett GH, Vogelbaum …
• A novel PARD3B-NUTM1 fusion in an aggressive primary CNS embryonal tumor in a young adult.
  Acta neuropathologica communications 2020 Ko K, Kitani T, Harris BT, Anaizi AN, Solomon D, Perry A, Toretsky J, Ozdemirli M
• DNA methylation profiling demonstrates superior diagnostic classification to RNA-sequencing in a case of metastatic meningioma.
  Acta neuropathologica communications 2020 Vasudevan HN, Castro MRH, Lee JC, Villanueva-Meyer JE, Bush NAO, McDermott MW, Solomon DA, Perry A, Magill ST, Raleigh DR
• Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution.
  Pituitary 2020 Asa SL, Asioli S, Bozkurt S, Casar-Borota O, Chinezu L, Comunoglu N, Cossu G, Cusimano M, Delgrange E, Earls P, Ezzat S, Gazioglu N, Grossman A, Guaraldi F, Hickman RA, Ikeda H, Jaffrain-Rea ML, …
• cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.
  Brain pathology (Zurich, Switzerland) 2020 Louis DN, Wesseling P, Aldape K, Brat DJ, Capper D, Cree IA, Eberhart C, Figarella-Branger D, Fouladi M, Fuller GN, Giannini C, Haberler C, Hawkins C, Komori T, Kros JM, Ng HK, Orr BA, Park SH, Paulus…
• Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition.
  Acta neuropathologica 2020 Mondal G, Lee JC, Ravindranathan A, Villanueva-Meyer JE, Tran QT, Allen SJ, Barreto J, Gupta R, Doo P, Van Ziffle J, Onodera C, Devine P, Grenert JP, Samuel D, Li R, Metrock LK, Jin LW, Antony R, …
• Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features.
  Acta neuropathologica 2020 Sloan EA, Hilz S, Gupta R, Cadwell C, Ramani B, Hofmann J, Kline CN, Banerjee A, Reddy A, Oberheim Bush NA, Chang S, Braunstein S, Chang EF, Raffel C, Gupta N, Sun PP, Kim JYH, Moes G, Alva E, Li R, …
• cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.
  Acta neuropathologica 2020 Brat DJ, Aldape K, Colman H, Figrarella-Branger D, Fuller GN, Giannini C, Holland EC, Jenkins RB, Kleinschmidt-DeMasters B, Komori T, Kros JM, Louis DN, McLean C, Perry A, Reifenberger G, Sarkar C, …
• Loss of H3K27 trimethylation by immunohistochemistry is frequent in oligodendroglioma, IDH-mutant and 1p/19q-codeleted, but is neither a sensitive nor a specific marker.
  Acta neuropathologica 2020 Pekmezci M, Phillips JJ, Dirilenoglu F, Atasever-Rezanko T, Tihan T, Solomon D, Bollen A, Perry A
• The "neuroepithelial tumor": Exchanging our trash can for an industrial size dumpster?
  Free neuropathology 2020 Perry A
• Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumors.
  Brain pathology (Zurich, Switzerland) 2019 Lee JC, Villanueva-Meyer JE, Ferris SP, Cham EM, Zucker J, Cooney T, Gilani A, Kleinschmidt-DeMasters BK, Trembath D, Mafra M, Chiang J, Ellison DW, Cho SJ, Horvai AE, Van Ziffle J, Onodera C, Devine …
• High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.
  International journal of radiation oncology, biology, physics 2019 Rogers CL, Won M, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Fogh SE, Youssef E, Deb N, Kwok Y, Robinson CG, Shu HK, Fisher BJ, Panet-Raymond V, McMillan WG, de Groot JF, Zhang P,…
• Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features.
  Brain pathology (Zurich, Switzerland) 2019 Lucas CG, Villanueva-Meyer JE, Whipple N, Oberheim Bush NA, Cooney T, Chang S, McDermott M, Berger M, Cham E, Sun PP, Putnam A, Zhou H, Bollo R, Cheshier S, Poppe MM, Fung KM, Sung S, Glenn C, Fan X, …
• A review of recently described genetic alterations in central nervous system tumors.
  Human pathology 2019 Lucas CG, Solomon DA, Perry A
• Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas.
  Acta neuropathologica 2019 Sloan EA, Cooney T, Oberheim Bush NA, Buerki R, Taylor J, Clarke JL, Torkildson J, Kline C, Reddy A, Mueller S, Banerjee A, Butowski N, Chang S, Mummaneni PV, Chou D, Tan L, Theodosopoulos P, …
• A Cerebellar High-Grade Neuroepithelial Tumour with BCOR Alteration in a five-year-old Child: A case report.
  Sultan Qaboos University medical journal 2019 Al-Battashi A, Al Hajri Z, Perry A, Al-Kindi H, Al-Ghaithi I
• Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival.
  Neuro-oncology advances 2019 Morin O, Chen WC, Nassiri F, Susko M, Magill ST, Vasudevan HN, Wu A, Vallières M, Gennatas ED, Valdes G, Pekmezci M, Alcaide-Leon P, Choudhury A, Interian Y, Mortezavi S, Turgutlu K, Bush NAO, Solberg…
• A case of recurrent epilepsy-associated rosette-forming glioneuronal tumor with anaplastic transformation in the absence of therapy.
  Neuropathology : official journal of the Japanese Society of Neuropathology 2019 Halfpenny A, Ferris SP, Grafe M, Woltjer R, Selden N, Nazemi K, Perry A, Solomon DA, Gultekin SH, Moore S, Olson S, Lawce H, Lucas L, Corless CL, Wood MD
• An unusual recurrent high-grade glioneuronal tumor with MAP2K1 mutation and CDKN2A/B homozygous deletion.
  Acta neuropathologica communications 2019 Cheaney B, Bowden S, Krause K, Sloan EA, Perry A, Solomon DA, Han SJ, Wood MD
• Data Sets for the Reporting of Tumors of the Central Nervous System: Recommendations From The International Collaboration on Cancer Reporting.
  Archives of pathology & laboratory medicine 2019 Louis DN, Wesseling P, Brandner S, Brat DJ, Ellison DW, Giangaspero F, Hattab EM, Hawkins C, Judge MJ, Kleinschmidt-DeMasters B, Komori T, McLean C, Paulus W, Perry A, Reifenberger G, Weller M, Rous B
• High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.
  Brain pathology (Zurich, Switzerland) 2019 Ferris SP, Velazquez Vega J, Aboian M, Lee JC, Van Ziffle J, Onodera C, Grenert JP, Saunders T, Chen YY, Banerjee A, Kline CN, Gupta N, Raffel C, Samuel D, Ruiz-Diaz I, Magaki S, Wilson D, Neltner J, …
• ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system.
  Acta neuropathologica 2019 Lucas CG, Gilani A, Solomon DA, Liang X, Maher OM, Chamyan G, Kleinschmidt-Demasters BK, Perry A
• cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updates.
  Brain pathology (Zurich, Switzerland) 2019 Louis DN, Ellison DW, Brat DJ, Aldape K, Capper D, Hawkins C, Paulus W, Perry A, Reifenberger G, Figarella-Branger D, von Deimling A, Wesseling P
• Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
  Journal of neuropathology and experimental neurology 2019 Torre M, Meredith DM, Dubuc A, Solomon DA, Perry A, Vasudevaraja V, Serrano J, Snuderl M, Ligon KL, Alexandrescu S
• Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma.
  Acta neuropathologica 2019 Lee JC, Mazor T, Lao R, Wan E, Diallo AB, Hill NS, Thangaraj N, Wendelsdorf K, Samuel D, Kline CN, Banerjee A, Auguste K, Raffel C, Gupta N, Berger M, Raleigh DR, Shai A, Phillips JJ, Bollen AW, Tihan…
• Primary intracranial sarcomas with DICER1 mutation often contain prominent eosinophilic cytoplasmic globules and can occur in the setting of neurofibromatosis type 1.
  Acta neuropathologica 2019 Lee JC, Villanueva-Meyer JE, Ferris SP, Sloan EA, Hofmann JW, Hattab EM, Williams BJ, Guo H, Torkildson J, Florez A, Van Ziffle J, Onodera C, Grenert JP, Cho SJ, Horvai AE, Jones DTW, Pfister SM, …
• Molecular and translational advances in meningiomas.
  Neuro-oncology 2019 Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, Hashizume R, James CD, Mawrin C, Noushmehr H, Perry A, Sahm F, Sloan A, Von Deimling A, Wen PY, Aldape K, Zadeh G, International …
• The Misclassification of Diffuse Gliomas: Rates and Outcomes.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Iorgulescu JB, Torre M, Harary M, Smith TR, Aizer AA, Reardon DA, Barnholtz-Sloan JS, Perry A
• Clinicopathologic features of anaplastic myxopapillary ependymomas.
  Brain pathology (Zurich, Switzerland) 2019 Lee JC, Sharifai N, Dahiya S, Kleinschmidt-DeMasters BK, Rosenblum MK, Reis GF, Samuel D, Siongco AM, Santi M, Storm PB, Ferris SP, Bollen AW, Pekmezci M, Solomon DA, Tihan T, Perry A
• The impact of histopathology and NAB2-STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma.
  Acta neuropathologica 2018 Fritchie K, Jensch K, Moskalev EA, Caron A, Jenkins S, Link M, Brown PD, Rodriguez FJ, Guajardo A, Brat D, Velázquez Vega JE, Perry A, Wu A, Raleigh DR, Santagata S, Louis DN, Brastianos PK, Kaplan A,…
• The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.
  Brain pathology (Zurich, Switzerland) 2018 Phillips JJ, Gong H, Chen K, Joseph NM, van Ziffle J, Bastian BC, Grenert JP, Kline CN, Mueller S, Banerjee A, Nicolaides T, Gupta N, Berger MS, Lee HS, Pekmezci M, Tihan T, Bollen AW, Perry A, Shieh …
• cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".
  Acta neuropathologica 2018 Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters BK, Perry A, Reifenberger G, Stupp R, von Deimling A, Weller M
• Preoperative and postoperative prediction of long-term meningioma outcomes.
  PloS one 2018 Gennatas ED, Wu A, Braunstein SE, Morin O, Chen WC, Magill ST, Gopinath C, Villaneueva-Meyer JE, Perry A, McDermott MW, Solberg TD, Valdes G, Raleigh DR
• Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterparts.
  Acta neuropathologica communications 2018 Lee J, Putnam AR, Chesier SH, Banerjee A, Raffel C, Van Ziffle J, Onodera C, Grenert JP, Bastian BC, Perry A, Solomon DA
• The genetic landscape of gliomas arising after therapeutic radiation.
  Acta neuropathologica 2018 López GY, Van Ziffle J, Onodera C, Grenert JP, Yeh I, Bastian BC, Clarke J, Oberheim Bush NA, Taylor J, Chang S, Butowski N, Banerjee A, Mueller S, Kline C, Torkildson J, Samuel D, Siongco A, Raffel C…
• Primary brain tumours in adults.
  Lancet (London, England) 2018 Lapointe S, Perry A, Butowski NA
• Myxoid glioneuronal tumor of the septum pellucidum and lateral ventricle is defined by a recurrent PDGFRA p.K385 mutation and DNT-like methylation profile.
  Acta neuropathologica 2018 Solomon DA, Korshunov A, Sill M, Jones DTW, Kool M, Pfister SM, Fan X, Bannykh S, Hu J, Danielpour M, Li R, Johnston J, Cham E, Cooney T, Sun PP, Oberheim Bush NA, McDermott M, Van Ziffle J, Onodera C…
• Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas.
  Translational oncology 2018 Luks TL, McKnight TR, Jalbert LE, Williams A, Neill E, Lobo KA, Persson AI, Perry A, Phillips JJ, Molinaro AM, Chang SM, Nelson SJ
• The genetic landscape of ganglioglioma.
  Acta neuropathologica communications 2018 Pekmezci M, Villanueva-Meyer JE, Goode B, Van Ziffle J, Onodera C, Grenert JP, Bastian BC, Chamyan G, Maher OM, Khatib Z, Kleinschmidt-DeMasters BK, Samuel D, Mueller S, Banerjee A, Clarke JL, Cooney …
• Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
  The Lancet. Oncology 2018 Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, Grund KB, Brugières L, Jones DTW, Pajtler KW, Morrissy AS, Kool M, Sturm D, Chavez L, Ernst A, Brabetz S, Hain M, Zichner T, …
• Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
  Journal of neurosurgery 2018 Chen WC, Magill ST, Wu A, Vasudevan HN, Morin O, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Braunstein SE, Raleigh DR
• Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
  The American journal of surgical pathology 2018 Johann PD, Bens S, Oyen F, Wagener R, Giannini C, Perry A, Raisanen JM, Reis GF, Nobusawa S, Arita K, Felsberg J, Reifenberger G, Agaimy A, Buslei R, Capper D, Pfister SM, Schneppenheim R, Siebert R, …
• Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation.
  Cell reports 2018 Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, Reis GF, Magill ST, Zhang J, Feng FY, Nicholaides T, Chang SM, Sneed PK, McDermott MW, Berger MS, Perry A, Raleigh DR
• DNA methylation-based classification of central nervous system tumours.
  Nature 2018 Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, Stichel D, Olar A, Engel NW, Lindenberg K, …
• Salvage therapy outcomes for atypical meningioma.
  Journal of neuro-oncology 2018 Chen WC, Hara J, Magill ST, Wu A, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Raleigh DR, Braunstein SE
• A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle.
  Nature communications 2018 Goode B, Mondal G, Hyun M, Ruiz DG, Lin YH, Van Ziffle J, Joseph NM, Onodera C, Talevich E, Grenert JP, Hewedi IH, Snuderl M, Brat DJ, Kleinschmidt-DeMasters BK, Rodriguez FJ, Louis DN, Yong WH, Lopes…
• Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation.
  Acta neuropathologica 2018 Iorgulescu JB, Van Ziffle J, Stevers M, Grenert JP, Bastian BC, Chavez L, Stichel D, Buchhalter I, Samuel D, Nicolaides T, Banerjee A, Mueller S, Gupta N, Tihan T, Bollen AW, Northcott PA, Kool M, …
• Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway.
  Acta neuropathologica 2018 Pekmezci M, Stevers M, Phillips JJ, Van Ziffle J, Bastian BC, Tsankova NM, Kleinschmidt-DeMasters BK, Rosenblum MK, Tihan T, Perry A, Solomon DA
• Presenting Symptoms and Prognostic Factors for Symptomatic Outcomes Following Resection of Meningioma.
  World neurosurgery 2017 Wu A, Garcia MA, Magill ST, Chen W, Vasudevan HN, Perry A, Theodosopoulos PV, McDermott MW, Braunstein SE, Raleigh DR
• Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
  Endocrine pathology 2017 Lee JC, Pekmezci M, Lavezo JL, Vogel H, Katznelson L, Fraenkel M, Harsh G, Dulai M, Perry A, Tihan T
• Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis.
  Brain pathology (Zurich, Switzerland) 2017 Korshunov A, Chavez L, Sharma T, Ryzhova M, Schrimpf D, Stichel D, Capper D, Sturm D, Kool M, Habel A, Kleinschmidt-DeMasters BK, Rosenblum M, Absalyamova O, Golanov A, Lichter P, Pfister SM, Jones …
• Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
  Brain pathology (Zurich, Switzerland) 2017 Wood MD, Tihan T, Perry A, Chacko G, Turner C, Pu C, Payne C, Yu A, Bannykh SI, Solomon DA
• Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression.
  Acta neuropathologica 2017 Lopez GY, Oberheim Bush NA, Phillips JJ, Bouffard JP, Moshel YA, Jaeckle K, Kleinschmidt-DeMasters BK, Rosenblum MK, Perry A, Solomon DA
• Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
  Journal of neurosurgery 2017 Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Brachman D, Jenrette JM, De Groot J, Bovi JA, Werner-Wasik M, Knisely JPS, Mehta MP
• Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1.
  Proceedings of the National Academy of Sciences of the United States of America 2017 Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, Smirnov IV, Marshall R, Souza CF, Shen Y, Viswanath P, Noushmehr H, Ronen SM, Jones SJM, Marra MA, Cairncross JG, Perry A, Nelson SJ, …
• SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors.
  Sarcoma 2017 Higham CS, Steinberg SM, Dombi E, Perry A, Helman LJ, Schuetze SM, Ludwig JA, Staddon A, Milhem MM, Rushing D, Jones RL, Livingston M, Goldman S, Moertel C, Wagner L, Janhofer D, Annunziata CM, Reinke…
• Biologically aggressive regions within glioblastoma identified by spin-lock contrast T1 relaxation in the rotating frame (T1ρ) MRI.
  Radiology case reports 2017 Barajas RF, Villanueva-Meyer J, Perry A, Berger M, Cha S
• Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history.
  Clinical neuropathology 2017 Chan AK, Han SJ, Choy W, Beleford D, Aghi MK, Berger MS, Shieh JT, Bollen AW, Perry A, Phillips JJ, Butowski N, Solomon DA
• Significance of H3K27me3 loss in the diagnosis of malignant peripheral nerve sheath tumors.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Pekmezci M, Cuevas-Ocampo AK, Perry A, Horvai AE
• Angiocentric glioma with MYB-QKI fusion located in the brainstem, rather than cerebral cortex.
  Acta neuropathologica 2017 Chan E, Bollen AW, Sirohi D, Van Ziffle J, Grenert JP, Kline CN, Tihan T, Perry A, Gupta N, Solomon DA
• A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.
  Neuro-oncology 2017 Banerjee A, Jakacki RI, Onar-Thomas A, Wu S, Nicolaides T, Young Poussaint T, Fangusaro J, Phillips J, Perry A, Turner D, Prados M, Packer RJ, Qaddoumi I, Gururangan S, Pollack IF, Goldman S, Doyle LA…
• Complete durable response of a pediatric anaplastic oligodendroglioma to temozolomide alone: Case report and review of literature.
  Pediatric blood & cancer 2017 Sorge C, Li R, Singh S, Reddy AT, Solomon DA, Perry A, Friedman GK
• Characterization of gliomas: from morphology to molecules.
  Virchows Archiv : an international journal of pathology 2017 Ferris SP, Hofmann JW, Solomon DA, Perry A
• Primary CNS Nonamyloidogenic Light Chain Deposition Disease: Case Report and Brief Review.
  International journal of surgical pathology 2017 Mercado JJ, Markert JM, Meador W, Chapman P, Perry A, Hackney JR
• Intraneural glomus tumor of "uncertain malignant potential" and with BRAF mutation in the median nerve - an unusual case.
  Clinical neuropathology 2017 Dahlin LB, Scherman P, Besjakov J, Lindberg E, Solomon DA, Horvai AE, Perry A
• Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview.
  Human pathology 2017 Miettinen MM, Antonescu CR, Fletcher CDM, Kim A, Lazar AJ, Quezado MM, Reilly KM, Stemmer-Rachamimov A, Stewart DR, Viskochil D, Widemann B, Perry A
• Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma.
  Acta neuropathologica communications 2017 López G, Oberheim Bush NA, Berger MS, Perry A, Solomon DA
• Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
  Neuro-oncology 2017 Kline CN, Joseph NM, Grenert JP, van Ziffle J, Talevich E, Onodera C, Aboian M, Cha S, Raleigh DR, Braunstein S, Torkildson J, Samuel D, Bloomer M, Campomanes AGA, Banerjee A, Butowski N, Raffel C, …
• Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.
  Neuro-oncology 2017 Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM, Brewster R, Bi WL, Agarwalla PK, Thorner AR, Reardon DA, Al-Mefty O, Wen PY, Alexander BM, van Hummelen P, Batchelor TT, Ligon KL…
• Metastatic clival chordoma: a case report of multiple extraneural metastases following resection and proton beam radiotherapy in a 5-year old boy.
  Journal of neurosurgery. Pediatrics 2017 Rutkowski MJ, Birk HS, Wood MD, Perry A, Nicolaides T, Ames CP, Gupta N
• Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
  Acta neuropathologica 2017 Pekmezci M, Rice T, Molinaro AM, Walsh KM, Decker PA, Hansen H, Sicotte H, Kollmeyer TM, McCoy LS, Sarkar G, Perry A, Giannini C, Tihan T, Berger MS, Wiemels JL, Bracci PM, Eckel-Passow JE, Lachance …
• Genetic confirmation that ependymoma can arise as part of multiple endocrine neoplasia type 1 (MEN1) syndrome.
  Acta neuropathologica 2017 Cuevas-Ocampo AK, Bollen AW, Goode B, Pajtler KW, Chavez L, Sharma T, Dai SC, McDermott M, Perry A, Korshunov A, Solomon DA
• Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
  Neuro-oncology 2017 Wahl M, Phillips JJ, Molinaro AM, Lin Y, Perry A, Haas-Kogan DA, Costello JF, Dayal M, Butowski N, Clarke JL, Prados M, Nelson S, Berger MS, Chang SM
• Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma.
  Journal of neuro-oncology 2017 Neill E, Luks T, Dayal M, Phillips JJ, Perry A, Jalbert LE, Cha S, Molinaro A, Chang SM, Nelson SJ
• Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy.
  Acta neuropathologica 2017 Louis DN, Aldape K, Brat DJ, Capper D, Ellison DW, Hawkins C, Paulus W, Perry A, Reifenberger G, Figarella-Branger D, Wesseling P, Batchelor TT, Cairncross JG, Pfister SM, Rutkowski S, Weller M, Wick …
• Erratum to: Surgical resection of fourth ventricular ependymomas: case series and technical nuances.
  Journal of neuro-oncology 2017 Winkler EA, Birk H, Safaee M, Yue JK, Burke JF, Viner JA, Pekmezci M, Perry A, Aghi MK, Berger MS, McDermott MW
• cIMPACT-NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification.
  Brain pathology (Zurich, Switzerland) 2016 Louis DN, Aldape K, Brat DJ, Capper D, Ellison DW, Hawkins C, Paulus W, Perry A, Reifenberger G, Figarella-Branger D, Wesseling P, Batchelor TT, Gregory Cairncross J, Pfister SM, Rutkowski S, Weller M…
• Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
  Cancer 2016 Hirbe AC, Kaushal M, Sharma MK, Dahiya S, Pekmezci M, Perry A, Gutmann DH
• Surgical resection of fourth ventricular ependymomas: case series and technical nuances.
  Journal of neuro-oncology 2016 Winkler EA, Birk H, Safaee M, Yue JK, Burke JF, Viner JA, Pekmezci M, Perry A, Aghi MK, Berger MS, McDermott MW
• Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process.
  Cancer research 2016 Ohba S, Mukherjee J, Johannessen TC, Mancini A, Chow TT, Wood M, Jones L, Mazor T, Marshall RE, Viswanath P, Walsh KM, Perry A, Bell RJ, Phillips JJ, Costello JF, Ronen SM, Pieper RO
• Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.
  Cancer discovery 2016 Johanns TM, Miller CA, Dorward IG, Tsien C, Chang E, Perry A, Uppaluri R, Ferguson C, Schmidt RE, Dahiya S, Ansstas G, Mardis ER, Dunn GP
• Intracranial Angiomatoid Fibrous Histiocytoma: Case Report and Literature Review.
  World neurosurgery 2016 Alshareef MA, Almadidy Z, Baker T, Perry A, Welsh CT, Vandergrift WA
• Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation.
  Acta neuropathologica 2016 Phillips JJ, Gong H, Chen K, Joseph NM, van Ziffle J, Jin LW, Bastian BC, Bollen AW, Perry A, Nicolaides T, Solomon DA, Shieh JT
• Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.
  Journal of neuro-oncology 2016 Han SJ, Reis G, Kohanbash G, Shrivastav S, Magill ST, Molinaro AM, McDermott MW, Theodosopoulos PV, Aghi MK, Berger MS, Butowski NA, Barani I, Phillips JJ, Perry A, Okada H
• Central nervous system involvement by myeloid sarcoma: a report of 12 cases and review of the literature.
  Clinical neuropathology 2016 Olar A, Lapadat R, Davidson CJ, Stein TD, Dahiya S, Perry A, Gheorghe G
• Treatment of IgG4-related pachymeningitis in a patient with steroid intolerance: The role of early use of rituximab.
  Journal of neuroimmunology 2016 Gospodarev V, Câmara J, Chakravarthy V, Perry A, Wood M, Dietz R, Wang J, De Los Reyes K, Raghavan R
• Primary Sellar Rhabdomyosarcoma Arising in Association With a Pituitary Adenoma.
  International journal of surgical pathology 2016 Duncan VE, Nabors LB, Warren PP, Conry RM, Willey CD, Perry A, Riley KO, Hackney JR
• WHO's arrived in 2016! An updated weather forecast for integrated brain tumor diagnosis.
  Brain tumor pathology 2016 Perry A
• IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age.
  Acta neuropathologica 2016 Ferris SP, Goode B, Joseph NM, Kline CN, Samuel D, Gupta N, Bollen A, Perry A, Mueller S, Solomon DA
• The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
  Acta neuropathologica 2016 Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW
• Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.
  Acta neuropathologica 2016 Hasselblatt M, Thomas C, Hovestadt V, Schrimpf D, Johann P, Bens S, Oyen F, Peetz-Dienhart S, Crede Y, Wefers A, Vogel H, Riemenschneider MJ, Antonelli M, Giangaspero F, Bernardo MC, Giannini C, Ud …
• Gliosarcomas lack BRAFV600E mutation, but a subset exhibit β-catenin nuclear localization.
  Neuropathology : official journal of the Japanese Society of Neuropathology 2016 Schwetye KE, Joseph NM, Al-Kateb H, Rich KM, Schmidt RE, Perry A, Gutmann DH, Dahiya S
• New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.
  Cell 2016 Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, Worst BC, Pajtler KW, Brabetz S, …
• Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
  Acta neuropathologica 2016 Röhrich M, Koelsche C, Schrimpf D, Capper D, Sahm F, Kratz A, Reuss J, Hovestadt V, Jones DT, Bewerunge-Hudler M, Becker A, Weis J, Mawrin C, Mittelbronn M, Perry A, Mautner VF, Mechtersheimer G, …
• Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
  Acta neuropathologica 2016 Qaddoumi I, Orisme W, Wen J, Santiago T, Gupta K, Dalton JD, Tang B, Haupfear K, Punchihewa C, Easton J, Mulder H, Boggs K, Shao Y, Rusch M, Becksfort J, Gupta P, Wang S, Lee RP, Brat D, Peter Collins…
• The severe side of the IgG4-related hypertrophic pachymeningitis disease spectrum.
  Neurology(R) neuroimmunology & neuroinflammation 2016 Schubert RD, Wood M, Levin MH, Perry A, Gelfand JM
• Genetics of Glioblastomas in Rare Anatomical Locations: Spinal Cord and Optic Nerve.
  Brain pathology (Zurich, Switzerland) 2016 Shows J, Marshall C, Perry A, Kleinschmidt-DeMasters BK
• Histologic classification of gliomas.
  Handbook of clinical neurology 2016 Perry A, Wesseling P
• Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations.
  Brain pathology (Zurich, Switzerland) 2015 Solomon DA, Wood MD, Tihan T, Bollen AW, Gupta N, Phillips JJ, Perry A
• Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature.
  Journal of neuropathology and experimental neurology 2015 Vaubel RA, Chen SG, Raleigh DR, Link MJ, Chicoine MR, Barani I, Jenkins SM, Aleff PA, Rodriguez FJ, Burger PC, Dahiya S, Perry A, Giannini C
• Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539.
  Neuro-oncology 2015 Rogers CL, Perry A, Pugh S, Vogelbaum MA, Brachman D, McMillan W, Jenrette J, Barani I, Shrieve D, Sloan A, Bovi J, Kwok Y, Burri SH, Chao ST, Spalding AC, Anscher MS, Bloom B, Mehta M
• Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.
  Neuro-oncology 2015 Butowski N, Colman H, De Groot JF, Omuro AM, Nayak L, Wen PY, Cloughesy TF, Marimuthu A, Haidar S, Perry A, Huse J, Phillips J, West BL, Nolop KB, Hsu HH, Ligon KL, Molinaro AM, Prados M
• Lack of BRAF-V600E Mutation in Papillary Tumor of the Pineal Region.
  Neurosurgery 2015 Cimino PJ, Gonzalez-Cuyar LF, Perry A, Dahiya S
• Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas--Same Entity or First Cousins?
  Brain pathology (Zurich, Switzerland) 2015 Alexandrescu S, Korshunov A, Lai SH, Dabiri S, Patil S, Li R, Shih CS, Bonnin JM, Baker JA, Du E, Scharnhorst DW, Samuel D, Ellison DW, Perry A
• Molecular Analysis of Pediatric Oligodendrogliomas Highlights Genetic Differences with Adult Counterparts and Other Pediatric Gliomas.
  Brain pathology (Zurich, Switzerland) 2015 Nauen D, Haley L, Lin MT, Perry A, Giannini C, Burger PC, Rodriguez FJ
• Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
  Cancer research 2015 Soroceanu L, Matlaf L, Khan S, Akhavan A, Singer E, Bezrookove V, Decker S, Ghanny S, Hadaczek P, Bengtsson H, Ohlfest J, Luciani-Torres MG, Harkins L, Perry A, Guo H, Soteropoulos P, Cobbs CS
• Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen.
  Acta neuropathologica 2015 Menke JR, Raleigh DR, Gown AM, Thomas S, Perry A, Tihan T
• A clinicopathologic study of 11 rosette-forming meningiomas: a rare and potentially confusing pattern.
  Acta neuropathologica 2015 Liverman C, Mafra M, Chuang SS, Shivane A, Chakrabarty A, Highley R, Hilton DA, Byrne NP, Wesseling P, Perry A
• Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
  The New England journal of medicine 2015 Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, Halder C, Hansen HM, McCoy …
• Oligodendroglioma: pathology, molecular mechanisms and markers.
  Acta neuropathologica 2015 Wesseling P, van den Bent M, Perry A
• CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.
  Journal of neuropathology and experimental neurology 2015 Reis GF, Pekmezci M, Hansen HM, Rice T, Marshall RE, Molinaro AM, Phillips JJ, Vogel H, Wiencke JK, Wrensch MR, Walsh KM, Perry A
• Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Hirbe AC, Dahiya S, Miller CA, Li T, Fulton RS, Zhang X, McDonald S, DeSchryver K, Duncavage EJ, Walrath J, Reilly KM, Abel HJ, Pekmezci M, Perry A, Ley TJ, Gutmann DH
• Primary intracranial angiomatoid fibrous histiocytoma presenting with anaemia and migraine-like headaches and aura as early clinical features.
  Cephalalgia : an international journal of headache 2015 Hansen JM, Larsen VA, Scheie D, Perry A, Skjøth-Rasmussen J
• Variably Protease-sensitive Prionopathy in an Apparent Cognitively Normal 93-Year-Old.
  Alzheimer disease and associated disorders 2015 Ghoshal N, Perry A, McKeel D, Schmidt RE, Carter D, Norton J, Zou WQ, Xiao X, Puoti G, Notari S, Gambetti P, Morris JC, Cairns NJ
• Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers.
  Acta neuropathologica 2015 Korshunov A, Ryzhova M, Hovestadt V, Bender S, Sturm D, Capper D, Meyer J, Schrimpf D, Kool M, Northcott PA, Zheludkova O, Milde T, Witt O, Kulozik AE, Reifenberger G, Jabado N, Perry A, Lichter P, …
• High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN).
  Acta neuropathologica 2015 Rodriguez FJ, Schniederjan MJ, Nicolaides T, Tihan T, Burger PC, Perry A
• 77-year-old woman with a dural-based mass. Marginal zone B-cell lymphoma (MZBCL).
  Brain pathology (Zurich, Switzerland) 2015 Okimoto RA, Perry A, Rubenstein JL
• Spinal non-melanotic schwannoma with extensive calcifications.
  Clinical neuropathology 2015 Chavez JA, Din NU, Memon WA, Perry A
• Practical molecular pathologic diagnosis of infiltrating gliomas.
  Surgical pathology clinics 2014 Pekmezci M, Perry A
• CNS intravascular large cell lymphoma in a patient with autoimmune hemolytic anemia.
  Neuropathology : official journal of the Japanese Society of Neuropathology 2014 Alexandrescu S, Orengo JP, Toossi S, Perry A, Treseler P, Hess C, Margeta M
• A 53-year-old woman with progressive headaches.
  Brain pathology (Zurich, Switzerland) 2014 Tanboon J, Pongpaibul A, Chawalparit O, Wasinrat J, Witthiwej T, Perry A
• Anaplastic chordoma with loss of INI1 and brachyury expression in a 2-year-old girl.
  Clinical neuropathology 2014 Chavez JA, Memon A, Perry A
• Letter in response to David N. Louis et al, International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading, Brain Pathology, doi: 10.1111/bpa.12171.
  Brain pathology (Zurich, Switzerland) 2014 Hainfellner J, Louis DN, Perry A, Wesseling P
• Low-grade small round cell tumor of the cauda equina with EWSR1-WT1 fusion and indolent clinical course.
  Human pathology 2014 Ud Din N, Pekmezci M, Javed G, Horvai AE, Ahmad Z, Faheem M, Navarro AL, López-Terrada D, Perry A
• Genetic markers in adult high-grade gliomas.
  Seminars in radiation oncology 2014 Pekmezci M, Perry A
• International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading.
  Brain pathology (Zurich, Switzerland) 2014 Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, Kleihues P, …
• A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas.
  Acta neuropathologica 2014 Venneti S, Santi M, Felicella MM, Yarilin D, Phillips JJ, Sullivan LM, Martinez D, Perry A, Lewis PW, Thompson CB, Judkins AR
• Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 Pekmezci M, Reuss DE, Hirbe AC, Dahiya S, Gutmann DH, von Deimling A, Horvai AE, Perry A
• A 67-year-old man with a lumbar spine lesion.
  Brain pathology (Zurich, Switzerland) 2014 Reis GF, Perry A
• Germ-line and somatic DICER1 mutations in pineoblastoma.
  Acta neuropathologica 2014 de Kock L, Sabbaghian N, Druker H, Weber E, Hamel N, Miller S, Choong CS, Gottardo NG, Kees UR, Rednam SP, van Hest LP, Jongmans MC, Jhangiani S, Lupski JR, Zacharin M, Bouron-Dal Soglio D, Huang A, …
• Isolated intracerebral light chain deposition disease: novel imaging and pathologic findings.
  Clinical imaging 2014 Yu JP, Wilson DM, Chang EF, Cotter J, Perry A, Mahindra A, Glastonbury CM
• A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma.
  Neuro-oncology 2014 Clarke JL, Molinaro AM, Phillips JJ, Butowski NA, Chang SM, Perry A, Costello JF, DeSilva AA, Rabbitt JE, Prados MD
• Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas.
  Neuro-oncology 2014 Sabha N, Knobbe CB, Maganti M, Al Omar S, Bernstein M, Cairns R, Çako B, von Deimling A, Capper D, Mak TW, Kiehl TR, Carvalho P, Garrett E, Perry A, Zadeh G, Guha A
• Apparent diffusion coefficient in glioblastoma with PNET-like components, a GBM variant.
  Journal of neuro-oncology 2014 Ali S, Joseph NM, Perry A, Barajas RF, Cha S
• CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity.
  Acta neuropathologica 2014 Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M, Kim SK, Ra YS, Nakamura H, Fangusaro J, Hwang E, Kiehna E, Toledano H, Wang Y, Shi Q, Johnston D, Michaud J, La Spina M, Buccoliero AM, …
• Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations.
  Acta neuropathologica 2014 de Kock L, Sabbaghian N, Plourde F, Srivastava A, Weber E, Bouron-Dal Soglio D, Hamel N, Choi JH, Park SH, Deal CL, Kelsey MM, Dishop MK, Esbenshade A, Kuttesch JF, Jacques TS, Perry A, Leichter H, …
• Previously unrecognized pattern of central nervous system hemangiopericytoma with pseudoglandular spaces.
  Clinical neuropathology 2014 Pekmezci M, Vlodavsky E, Perry A
• A blustery wind of change.
  Brain pathology (Zurich, Switzerland) 2014 Perry A
• Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
  Cancer cell 2014 Kool M, Jones DT, Jäger N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, Milde T, Bourdeaut F, Ryzhova M, Sturm D, Pfaff E, Stark S, Hutter S, Seker-Cin H, Johann P, …
• IgG4 overexpression is rare in meningiomas with a prominent inflammatory component: a review of 16 cases.
  Brain pathology (Zurich, Switzerland) 2014 Lal A, Dahiya S, Gonzales M, Hiniker A, Prayson R, Kleinschmidt-DeMasters BK, Perry A
• BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
  Neuro-oncology 2013 Hirbe AC, Pekmezci M, Dahiya S, Apicelli AJ, Van Tine BA, Perry A, Gutmann DH
• Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity.
  Acta neuropathologica 2013 Korshunov A, Sturm D, Ryzhova M, Hovestadt V, Gessi M, Jones DT, Remke M, Northcott P, Perry A, Picard D, Rosenblum M, Antonelli M, Aronica E, Schüller U, Hasselblatt M, Woehrer A, Zheludkova O, …
• BRAF-V600E mutation in pediatric and adult glioblastoma.
  Neuro-oncology 2013 Dahiya S, Emnett RJ, Haydon DH, Leonard JR, Phillips JJ, Perry A, Gutmann DH
• A 73 year-old man with a mass at the foramen magnum.
  Brain pathology (Zurich, Switzerland) 2013 Allinson KS, Kolias AG, Philippou Y, Bulters DO, Fisher C, Perry A, Dean AF
• The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features.
  Journal of neuro-oncology 2013 Cykowski MD, Allen RA, Kanaly AC, Fung KM, Marshall R, Perry A, Stolzenberg ED, Dunn ST
• Atypical teratoid/rhabdoid tumor with ganglioglioma-like differentiation: case report and review of the literature.
  Human pathology 2013 Krishnan C, Vogel H, Perry A
• Cortical ependymoma with unusual histologic features.
  Clinical neuropathology 2013 Hiniker A, Lee HS, Chang S, Berger M, Perry A
• Practicing neuropathology under great adversity.
  Brain pathology (Zurich, Switzerland) 2013 Perry A
• Probable IgG4-related pachymeningitis: a case with transverse sinus obliteration.
  Clinical neuropathology 2013 Tanboon J, Felicella MM, Bilbao J, Mainprize T, Perry A
• The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013 Abedalthagafi M, Phillips JJ, Kim GE, Mueller S, Haas-Kogen DA, Marshall RE, Croul SE, Santi MR, Cheng J, Zhou S, Sullivan LM, Martinez-Lage M, Judkins AR, Perry A
• Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013 Reis GF, Bloomer MM, Perry A, Phillips JJ, Grenert JP, Karnezis AN, Tihan T
• Neuropathology of brain metastases.
  Surgical neurology international 2013 Pekmezci M, Perry A
• Adult with cerebellar anaplastic pilocytic astrocytoma associated with BRAF V600E mutation and p16 loss.
  Clinical neuropathology 2013 Yeo YH, Byrne NP, Counelis GJ, Perry A
• Gliosarcoma arising from an oligodendroglioma (oligosarcoma).
  Clinical neuropathology 2013 Hiniker A, Hagenkord JM, Powers MP, Aghi MK, Prados MD, Perry A
• Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomas.
  Journal of neuropathology and experimental neurology 2013 Venneti S, Felicella MM, Coyne T, Phillips JJ, Gorovets D, Huse JT, Kofler J, Lu C, Tihan T, Sullivan LM, Santi M, Judkins AR, Perry A, Thompson CB
• PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma.
  Brain pathology (Zurich, Switzerland) 2013 Phillips JJ, Aranda D, Ellison DW, Judkins AR, Croul SE, Brat DJ, Ligon KL, Horbinski C, Venneti S, Zadeh G, Santi M, Zhou S, Appin CL, Sioletic S, Sullivan LM, Martinez-Lage M, Robinson AE, Yong WH, …
• Gratitude for a job well done!
  Brain pathology (Zurich, Switzerland) 2013 Perry A
• Intracranial atherosclerotic disease associated with moyamoya collateral formation: histopathological findings.
  Journal of neurosurgery 2013 Jiang T, Perry A, Dacey RG, Zipfel GJ, Derdeyn CP
• Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jahangiri A, De Lay M, Miller LM, Carbonell WS, Hu YL, Lu K, Tom MW, Paquette J, Tokuyasu TA, Tsao S, Marshall R, Perry A, Bjorgan KM, Chaumeil MM, Ronen SM, Bergers G, Aghi MK
• PDGFRA gain in low-grade diffuse gliomas.
  Journal of neuropathology and experimental neurology 2013 Motomura K, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nakazato Y, Tanaka Y, Nonoguchi N, Pierscianek D, Kim YH, Mariani L, Vital A, Perry A, Ohgaki H
• Reactive retinal astrocytic tumors (so-called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases.
  American journal of ophthalmology 2012 Poole Perry LJ, Jakobiec FA, Zakka FR, Reichel E, Herwig MC, Perry A, Brat DJ, Grossniklaus HE
• LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR).
  Acta neuropathologica 2012 Korshunov A, Ryzhova M, Jones DT, Northcott PA, van Sluis P, Volckmann R, Koster J, Versteeg R, Cowdrey C, Perry A, Picard D, Rosenblum M, Giangaspero F, Aronica E, Schüller U, Hasselblatt M, Collins …
• Meningiomas in pregnancy: a clinicopathologic study of 17 cases.
  Neurosurgery 2012 Lusis EA, Scheithauer BW, Yachnis AT, Fischer BR, Chicoine MR, Paulus W, Perry A
• Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development.
  Brain pathology (Zurich, Switzerland) 2012 Aref D, Moffatt CJ, Agnihotri S, Ramaswamy V, Dubuc AM, Northcott PA, Taylor MD, Perry A, Olson JM, Eberhart CG, Croul SE
• Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012 Joseph NM, Phillips J, Dahiya S, M Felicella M, Tihan T, Brat DJ, Perry A
• Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity.
  Acta neuropathologica 2012 Rodriguez FJ, Perry A, Rosenblum MK, Krawitz S, Cohen KJ, Lin D, Mosier S, Lin MT, Eberhart CG, Burger PC
• Intracerebral pseudotumors in a family with cerebroretinal vasculopathy.
  Neurology. Clinical practice 2012 Sarkar K, Way C, Hiniker A, Brock R, Perry A, Verro P
• Lessons from the berlioz requiem.
  Brain pathology (Zurich, Switzerland) 2012 Perry A
• Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas.
  Acta neuropathologica 2012 Ellezam B, Theeler BJ, Walbert T, Mammoser AG, Horbinski C, Kleinschmidt-DeMasters BK, Perry A, Puduvalli V, Fuller GN, Bruner JM, Aldape KD
• A common 8q (MYC) amplification detected in a multifocal anaplastic astrocytoma by SNP array karyotyping.
  Clinical neuropathology 2012 Felicella MM, Hagenkord JM, Kash SF, Powers MP, Berger MS, Perry A
• Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss.
  Brain pathology (Zurich, Switzerland) 2012 Kim YH, Nonoguchi N, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Mariani L, Giangaspero F, Tanaka Y, Nakazato Y, Vital A, Mittelbronn M, Perry A, Ohgaki H
• Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.
  Cancer cell 2012 Swartling FJ, Savov V, Persson AI, Chen J, Hackett CS, Northcott PA, Grimmer MR, Lau J, Chesler L, Perry A, Phillips JJ, Taylor MD, Weiss WA
• Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy.
  Proceedings of the National Academy of Sciences of the United States of America 2012 Huillard E, Hashizume R, Phillips JJ, Griveau A, Ihrie RA, Aoki Y, Nicolaides T, Perry A, Waldman T, McMahon M, Weiss WA, Petritsch C, James CD, Rowitch DH
• Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement.
  Neuro-oncology 2012 Bien-Willner GA, López-Terrada D, Bhattacharjee MB, Patel KU, Stankiewicz P, Lupski JR, Pfeifer JD, Perry A
• Cerebellar anaplastic pilocytic astrocytoma in a patient of neurofibromatosis type-1: case report and review of the literature.
  Clinical neurology and neurosurgery 2012 Hsieh MS, Ho JT, Lin LW, Tu PH, Perry A, Huang AP
• A 39 year-old man with a cerebellar mass and pancytopenia.
  Brain pathology (Zurich, Switzerland) 2012 Gru AA, Fulling K, Perry A
• Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems.
  Acta neuropathologica 2012 Rodriguez FJ, Folpe AL, Giannini C, Perry A
• Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype.
  Journal of neuropathology and experimental neurology 2012 Goldhoff P, Clarke J, Smirnov I, Berger MS, Prados MD, James CD, Perry A, Phillips JJ
• Intracranial subdural osteoma: a rare benign tumor that can be differentiated from other calcified intracranial lesions utilizing MR imaging.
  Journal of neuroradiology = Journal de neuroradiologie 2011 Barajas RF, Perry A, Sughrue M, Aghi M, Cha S
• Experiencing Japanese utopia.
  Brain pathology (Zurich, Switzerland) 2011 Perry A
• Malignant meningiomas with epithelial (adenocarcinoma-like) metaplasia: a study of 3 cases.
  Neurosurgery 2011 Patil S, Scheithauer BW, Strom RG, Mafra M, Chicoine MR, Perry A
• Oligodendrogliomas in children.
  Journal of neuro-oncology 2011 Creach KM, Rubin JB, Leonard JR, Limbrick DD, Smyth MD, Dacey R, Rich KM, Dowling JL, Grubb RL, Linette GP, King AA, Michalski JM, Park TS, Perry A, Simpson JR, Mansur DB
• Identification of transcriptional regulatory networks specific to pilocytic astrocytoma.
  BMC medical genomics 2011 Deshmukh H, Yu J, Shaik J, MacDonald TJ, Perry A, Payton JE, Gutmann DH, Watson MA, Nagarajan R
• Formula for success =3A + 4C + F.
  Brain pathology (Zurich, Switzerland) 2011 Perry A
• Pathology of pineal parenchymal tumors.
  Neurosurgery clinics of North America 2011 Han SJ, Clark AJ, Ivan ME, Parsa AT, Perry A
• Adult medulloblastoma comprises three major molecular variants.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Remke M, Hielscher T, Northcott PA, Witt H, Ryzhova M, Wittmann A, Benner A, von Deimling A, Scheurlen W, Perry A, Croul S, Kulozik AE, Lichter P, Taylor MD, Pfister SM, Korshunov A
• Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas.
  Brain pathology (Zurich, Switzerland) 2011 Horbinski C, Kofler J, Yeaney G, Camelo-Piragua S, Venneti S, Louis DN, Perry A, Murdoch G, Nikiforova M
• Does there always need to be brain pathology in brain pathology?
  Brain pathology (Zurich, Switzerland) 2011 Perry A
• Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Yu J, Deshmukh H, Payton JE, Dunham C, Scheithauer BW, Tihan T, Prayson RA, Guha A, Bridge JA, Ferner RE, Lindberg GM, Gutmann RJ, Emnett RJ, Salavaggione L, Gutmann DH, Nagarajan R, Watson MA, Perry …
• Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
  Acta neuropathologica 2011 Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, Kenney AM, Brat DJ, Perry A, Yong WH, Taylor RE, Bailey S, Clifford SC, Gilbertson RJ
• Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade.
  Brain pathology (Zurich, Switzerland) 2011 Horbinski C, Miller CR, Perry A
• Identification of gene markers associated with aggressive meningioma by filtering across multiple sets of gene expression arrays.
  Journal of neuropathology and experimental neurology 2011 Stuart JE, Lusis EA, Scheck AC, Coons SW, Lal A, Perry A, Gutmann DH
• Molecular diagnostics in neuro-oncology. Introduction.
  Brain pathology (Zurich, Switzerland) 2011 Perry A
• Lack of HER2 overexpression and amplification in small intestinal adenocarcinoma.
  American journal of clinical pathology 2010 Chan OT, Chen ZM, Chung F, Kawachi K, Phan DC, Himmelfarb E, Lin F, Perry A, Wang HL
• Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors.
  The American journal of surgical pathology 2010 Johnson MW, Eberhart CG, Perry A, Tihan T, Cohen KJ, Rosenblum MK, Rais-Bahrami S, Goldthwaite P, Burger PC
• Pineal tumors.
  Advances in anatomic pathology 2010 Dahiya S, Perry A
• Postoperative imaging surveillance in pediatric pilocytic astrocytomas.
  Journal of neurosurgery. Pediatrics 2010 Dorward IG, Luo J, Perry A, Gutmann DH, Mansur DB, Rubin JB, Leonard JR
• Glioblastomas with giant cell and sarcomatous features in patients with Turcot syndrome type 1: a clinicopathological study of 3 cases.
  Neurosurgery 2010 Lusis EA, Travers S, Jost SC, Perry A
• Pathological classification and molecular genetics of meningiomas.
  Journal of neuro-oncology 2010 Mawrin C, Perry A
• Anaplastic meningioma arising from a radiologically diagnosed arachnoid cyst: case report.
  Neurosurgery 2010 Lwu S, Starreveld YP, Branson J, Perry A
• Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma.
  Radiation oncology (London, England) 2010 Wernicke AG, Dicker AP, Whiton M, Ivanidze J, Hyslop T, Hammond EH, Perry A, Andrews DW, Kenyon L
• Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall.
  Acta neuropathologica 2010 Perry A, Burton SS, Fuller GN, Robinson CA, Palmer CA, Resch L, Bigio EH, Gujrati M, Rosenblum MK
• Newborn twins of neuropathology education.
  Brain pathology (Zurich, Switzerland) 2010 Perry A, Perry A
• Rosette-forming glioneuronal tumors of the posterior fossa.
  Journal of neurosurgery. Pediatrics 2010 Shah MN, Leonard JR, Perry A
• Brainstem glioma presenting as pruritus in children with neurofibromatosis-1.
  Journal of pediatric hematology/oncology 2009 Darken RS, Bogitch R, Leonard J, Perry A, McKinstry RC, Gutmann DH, Rubin JB
• Interobserver and intraobserver reproducibility in focal cortical dysplasia (malformations of cortical development).
  Epilepsia 2009 Chamberlain WA, Cohen ML, Gyure KA, Kleinschmidt-DeMasters BK, Perry A, Powell SZ, Qian J, Staugaitis SM, Prayson RA
• A novel murine model for localized radiation necrosis and its characterization using advanced magnetic resonance imaging.
  International journal of radiation oncology, biology, physics 2009 Jost SC, Hope A, Kiehl E, Perry A, Travers S, Garbow JR
• Growing pains and the brain pathology stimulus package.
  Brain pathology (Zurich, Switzerland) 2009 Perry A
• Receptor tyrosine kinases in sinonasal undifferentiated carcinomas--evaluation for EGFR, c-KIT, and HER2/neu expression.
  Head & neck 2009 Chernock RD, Perry A, Pfeifer JD, Holden JA, Lewis JS
• Central nervous system primitive neuroectodermal tumors: a clinicopathologic and genetic study of 33 cases.
  Brain pathology (Zurich, Switzerland) 2009 Behdad A, Perry A
• Papillary carcinoma of the breast lacks evidence of RET rearrangements despite morphological similarities to papillary thyroid carcinoma.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009 Hameed O, Perry A, Banerjee R, Zhu X, Pfeifer JD
• Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion.
  The American journal of surgical pathology 2009 Lennerz JK, Perry A, Mills JC, Huettner PC, Pfeifer JD
• Clinicopathologic features of recurrent dysembryoplastic neuroepithelial tumor and rare malignant transformation: a report of 5 cases and review of the literature.
  Journal of neuro-oncology 2009 Ray WZ, Blackburn SL, Casavilca-Zambrano S, Barrionuevo C, Orrego JE, Heinicke H, Dowling JL, Perry A
• Histopathologic predictors of pilocytic astrocytoma event-free survival.
  Acta neuropathologica 2009 Tibbetts KM, Emnett RJ, Gao F, Perry A, Gutmann DH, Leonard JR
• Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes.
  Journal of neuropathology and experimental neurology 2008 Rodriguez FJ, Giannini C, Asmann YW, Sharma MK, Perry A, Tibbetts KM, Jenkins RB, Scheithauer BW, Anant S, Jenkins S, Eberhart CG, Sarkaria JN, Gutmann DH
• Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Goldhoff P, Warrington NM, Limbrick DD, Hope A, Woerner BM, Jackson E, Perry A, Piwnica-Worms D, Rubin JB
• Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.
  International journal of cancer 2008 Tepel M, Roerig P, Wolter M, Gutmann DH, Perry A, Reifenberger G, Riemenschneider MJ
• Gray zones in brain tumor classification: evolving concepts.
  Advances in anatomic pathology 2008 Trembath D, Miller CR, Perry A
• Use of thalidomide to diminish growth velocity in a life-threatening congenital intracranial hemangioma.
  Journal of neurosurgery. Pediatrics 2008 Frei-Jones M, McKinstry RC, Perry A, Leonard JR, Park TS, Rubin JB
• A GBM by any other name?
  Brain pathology (Zurich, Switzerland) 2008 Perry A
• Large cell medulloblastoma with myogenic and melanotic differentiation: a case report with molecular analysis.
  Journal of neuro-oncology 2008 Polydorides AD, Perry A, Edgar MA
• Ependymal tumors with sarcomatous change ("ependymosarcoma"): a clinicopathologic and molecular cytogenetic study.
  The American journal of surgical pathology 2008 Rodriguez FJ, Scheithauer BW, Perry A, Oliveira AM, Jenkins RB, Oviedo A, Mork SJ, Palmer CA, Burger PC
• Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.
  Brain pathology (Zurich, Switzerland) 2008 Perry A, Miller CR, Gujrati M, Scheithauer BW, Zambrano SC, Jost SC, Raghavan R, Qian J, Cochran EJ, Huse JT, Holland EC, Burger PC, Rosenblum MK
• Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas.
  Brain pathology (Zurich, Switzerland) 2008 Patil S, Perry A, Maccollin M, Dong S, Betensky RA, Yeh TH, Gutmann DH, Stemmer-Rachamimov AO
• Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients.
  Journal of neuropathology and experimental neurology 2008 Rodriguez FJ, Perry A, Gutmann DH, O'Neill BP, Leonard J, Bryant S, Giannini C
• Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma.
  Cancer research 2008 Hegedus B, Banerjee D, Yeh TH, Rothermich S, Perry A, Rubin JB, Garbow JR, Gutmann DH
• Primary intracerebral angiomatoid fibrous histiocytoma: report of a case with a t(12;22)(q13;q12) causing type 1 fusion of the EWS and ATF-1 genes.
  The American journal of surgical pathology 2008 Dunham C, Hussong J, Seiff M, Pfeifer J, Perry A
• C-MYC rearrangements are frequent in aggressive mature B-Cell lymphoma with atypical morphology.
  International journal of clinical and experimental pathology 2008 Zhao XF, Hassan A, Perry A, Ning Y, Stass SA, Dehner LP
• Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.
  Cancer research 2007 Warrington NM, Woerner BM, Daginakatte GC, Dasgupta B, Perry A, Gutmann DH, Rubin JB
• Malignant rhabdoid tumor mimicking hepatoblastoma: a case report and literature review.
  Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2007 Wagner LM, Garrett JK, Ballard ET, Hill DA, Perry A, Biegel JA, Collins MH
• Colocalized cellular schwannoma and plexiform neurofibroma in the absence of neurofibromatosis. Case report.
  Journal of neurosurgery 2007 Spinner RJ, Scheithauer BW, Perry A, Amrami KK, Emnett R, Gutmann DH
• Cytologic diagnosis of Ewing sarcoma/peripheral neuroectodermal tumor with paired prospective molecular genetic analysis.
  Cancer 2007 Sanati S, Lu DW, Schmidt E, Perry A, Dehner LP, Pfeifer JD
• Primary Ewing sarcoma of the brain: a case report and literature review.
  Diagnostic molecular pathology : the American journal of surgical pathology, part B 2007 Kazmi SA, Perry A, Pressey JG, Wellons JC, Hammers Y, Palmer CA
• DNA sequence of the translocation breakpoints in undifferentiated embryonal sarcoma arising in mesenchymal hamartoma of the liver harboring the t(11;19)(q11;q13.4) translocation.
  Genes, chromosomes & cancer 2007 Rajaram V, Knezevich S, Bove KE, Perry A, Pfeifer JD
• Congenital glioblastoma: a clinicopathologic and genetic analysis.
  Brain pathology (Zurich, Switzerland) 2007 Brat DJ, Shehata BM, Castellano-Sanchez AA, Hawkins C, Yost RB, Greco C, Mazewski C, Janss A, Ohgaki H, Perry A
• Atypical teratoid/rhabdoid tumor arising in the setting of a pleomorphic xanthoastrocytoma.
  Journal of neuro-oncology 2007 Chacko G, Chacko AG, Dunham CP, Judkins AR, Biegel JA, Perry A
• Gliosarcoma with primitive neuroectodermal differentiation: case report and review of the literature.
  Journal of neuro-oncology 2007 Kaplan KJ, Perry A
• Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature.
  Journal of neuro-oncology 2007 Zarovnaya EL, Pallatroni HF, Hug EB, Ball PA, Cromwell LD, Pipas JM, Fadul CE, Meyer LP, Park JP, Biegel JA, Perry A, Rhodes CH
• Glioblastoma.
  Archives of pathology & laboratory medicine 2007 Miller CR, Perry A
• Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Worley LA, Onken MD, Person E, Robirds D, Branson J, Char DH, Perry A, Harbour JW
• Tubedown expression correlates with the differentiation status and aggressiveness of neuroblastic tumors.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Martin DT, Gendron RL, Jarzembowski JA, Perry A, Collins MH, Pushpanathan C, Miskiewicz E, Castle VP, Paradis H
• Embryonal tumor with abundant neuropil and true rosettes (ETANTR): report of a case with prominent neurocytic differentiation.
  Journal of neuro-oncology 2007 Dunham C, Sugo E, Tobias V, Wills E, Perry A
• Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma.
  Archives of pathology & laboratory medicine 2007 Aldape K, Burger PC, Perry A
• Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin.
  Cancer research 2007 Sharma MK, Mansur DB, Reifenberger G, Perry A, Leonard JR, Aldape KD, Albin MG, Emnett RJ, Loeser S, Watson MA, Nagarajan R, Gutmann DH
• The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4.
  Neurosurgery 2007 Chicoine MR, Zahner M, Won EK, Kalra RR, Kitamura T, Perry A, Higashikubo R
• Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo.
  Cancer research 2007 Yang L, Jackson E, Woerner BM, Perry A, Piwnica-Worms D, Rubin JB
• Histological classification and molecular genetics of meningiomas.
  The Lancet. Neurology 2006 Riemenschneider MJ, Perry A, Reifenberger G
• Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Miller CR, Dunham CP, Scheithauer BW, Perry A
• Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum.
  Acta neuropathologica 2006 Rodriguez FJ, Scheithauer BW, Robbins PD, Burger PC, Hessler RB, Perry A, Abell-Aleff PC, Mierau GW
• 1p/19q chromosome deletions in metastatic oligodendroglioma.
  Journal of neuro-oncology 2006 Merrell R, Nabors LB, Perry A, Palmer CA
• Expression of epidermal growth factor receptor in squamous cell carcinomas of the anal canal is independent of gene amplification.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006 Alvarez G, Perry A, Tan BR, Wang HL
• Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues.
  Cancer research 2006 Miller SJ, Rangwala F, Williams J, Ackerman P, Kong S, Jegga AG, Kaiser S, Aronow BJ, Frahm S, Kluwe L, Mautner V, Upadhyaya M, Muir D, Wallace M, Hagen J, Quelle DE, Watson MA, Perry A, Gutmann DH, …
• Cancer therapy-associated CNS neuropathology: an update and review of the literature.
  Acta neuropathologica 2006 Perry A, Schmidt RE
• Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006 Bridge RS, Rajaram V, Dehner LP, Pfeifer JD, Perry A
• Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.
  Journal of neuro-oncology 2006 Bannykh SI, Stolt CC, Kim J, Perry A, Wegner M
• Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies.
  Cancer research 2005 Woerner BM, Warrington NM, Kung AL, Perry A, Rubin JB
• Expression and function of somatostatin receptors in peripheral nerve sheath tumors.
  Journal of neuropathology and experimental neurology 2005 Mawrin C, Schulz S, Hellwig-Patyk A, Kirches E, Roessner A, Lendeckel U, Firsching R, Vorwerk CK, Keilhoff G, Dietzmann K, Grimm K, Lindberg G, Gutmann DH, Scheithauer BW, Perry A
• Mixed glioneuronal tumors of the spinal cord in two children.
  Acta neuropathologica 2005 Syed S, Rajaram V, Leonard JR, Perry A, Raghavan R
• Commentary: Classification and grading of pituitary tumors. Observations of two working neuropathologists.
  Acta neuropathologica 2005 Perry A, Scheithauer BW
• Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
  Cancer research 2005 Lusis EA, Watson MA, Chicoine MR, Lyman M, Roerig P, Reifenberger G, Gutmann DH, Perry A
• The efficacy of radiation therapy in the management of grade I astrocytomas.
  Journal of neuro-oncology 2005 Kidd EA, Mansur DB, Leonard JR, Michalski JM, Simpson JR, Perry A
• Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningioma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 Tu PH, Giannini C, Judkins AR, Schwalb JM, Burack R, O'Neill BP, Yachnis AT, Burger PC, Scheithauer BW, Perry A
• A 15-year-old female with progressive myelopathy.
  Brain pathology (Zurich, Switzerland) 2005 Siami-Namini K, Shuey-Drake R, Wilson D, Francel P, Perry A, Fung KM
• Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005 Rajaram V, Gutmann DH, Prasad SK, Mansur DB, Perry A
• High throughput screening of meningioma biomarkers using a tissue microarray.
  Journal of neuro-oncology 2005 Lusis EA, Chicoine MR, Perry A
• INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005 Perry A, Fuller CE, Judkins AR, Dehner LP, Biegel JA
• Molecular diagnostics in central nervous system tumors.
  Advances in anatomic pathology 2005 Fuller CE, Perry A
• Chasing your dural tail: Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas: In regard to DiBiase et al. (Int J Radiat Oncol Biol Phys 2004;60:1515-1519).
  International journal of radiation oncology, biology, physics 2005 Rogers L, Jensen R, Perry A
• INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma.
  Journal of neuropathology and experimental neurology 2005 Judkins AR, Burger PC, Hamilton RL, Kleinschmidt-DeMasters B, Perry A, Pomeroy SL, Rosenblum MK, Yachnis AT, Zhou H, Rorke LB, Biegel JA
• Incidental pediatric intraparenchymal xanthogranuloma: case report and review of the literature.
  Journal of neurosurgery 2005 Ashley WW, Narayan P, Park TS, Tu PH, Perry A, Leonard JR
• Meningothelial hyperplasia: a detailed clinicopathologic, immunohistochemical and genetic study of 11 cases.
  Brain pathology (Zurich, Switzerland) 2005 Perry A, Lusis EA, Gutmann DH
• Postoperative radiation therapy for grade II and III intracranial ependymoma.
  International journal of radiation oncology, biology, physics 2005 Mansur DB, Perry A, Rajaram V, Michalski JM, Park TS, Leonard JR, Luchtman-Jones L, Rich KM, Grigsby PW, Lockett MA, Wahab SH, Simpson JR
• Spindle cell oncocytoma of the adenohypophysis: report of two recurrent cases.
  The American journal of surgical pathology 2005 Kloub O, Perry A, Tu PH, Lipper M, Lopes MB
• Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults.
  Brain pathology (Zurich, Switzerland) 2005 Raisanen J, Biegel JA, Hatanpaa KJ, Judkins A, White CL, Perry A
• EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma.
  Human pathology 2005 Covinsky M, Gong S, Rajaram V, Perry A, Pfeifer J
• Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.
  Cancer research 2005 Dasgupta B, Li W, Perry A, Gutmann DH
• Insights into meningioangiomatosis with and without meningioma: a clinicopathologic and genetic series of 24 cases with review of the literature.
  Brain pathology (Zurich, Switzerland) 2005 Perry A, Kurtkaya-Yapicier O, Scheithauer BW, Robinson S, Prayson RA, Kleinschmidt-DeMasters BK, Stemmer-Rachamimov AO, Gutmann DH
• Natural history of neurofibromatosis 1-associated optic nerve glioma in mice.
  Annals of neurology 2005 Bajenaru ML, Garbow JR, Perry A, Hernandez MR, Gutmann DH
• Rhabdoid glioblastoma in an adult.
  Pathology 2004 Fung KM, Perry A, Payner TD, Shan Y
• Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
  Cancer 2004 Perry A, Aldape KD, George DH, Burger PC
• Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers.
  Human pathology 2004 Rajaram V, Brat DJ, Perry A
• Molecular pathogenesis of meningiomas.
  Journal of neuro-oncology 2004 Perry A, Gutmann DH, Reifenberger G
• Notch1 and notch2 have opposite effects on embryonal brain tumor growth.
  Cancer research 2004 Fan X, Mikolaenko I, Elhassan I, Ni X, Wang Y, Ball D, Brat DJ, Perry A, Eberhart CG
• Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival.
  Journal of neuropathology and experimental neurology 2004 Surace EI, Lusis E, Murakami Y, Scheithauer BW, Perry A, Gutmann DH
• Medullomyoblastoma: a radiographic and clinicopathologic analysis of six cases and review of the literature.
  Cancer 2004 Helton KJ, Fouladi M, Boop FA, Perry A, Dalton J, Kun L, Fuller C
• Glioneuronal tumours in neurofibromatosis type 1: MRI-pathological study.
  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2004 Fedi M, Anne Mitchell L, Kalnins RM, Gutmann DH, Perry A, Newton M, Brodtmann A, Berkovic SF
• Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors.
  Brain pathology (Zurich, Switzerland) 2004 Watson MA, Perry A, Tihan T, Prayson RA, Guha A, Bridge J, Ferner R, Gutmann DH
• Genetic and expression profiles of cerebellar liponeurocytomas.
  Brain pathology (Zurich, Switzerland) 2004 Horstmann S, Perry A, Reifenberger G, Giangaspero F, Huang H, Hara A, Masuoka J, Rainov NG, Bergmann M, Heppner FL, Brandner S, Chimelli L, Montagna N, Jackson T, Davis DG, Markesbery WR, Ellison DW, …
• Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature.
  Neuro-oncology 2004 Armanios MY, Grossman SA, Yang SC, White B, Perry A, Burger PC, Orens JB
• Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.
  Neuro-oncology 2004 Brat DJ, Seiferheld WF, Perry A, Hammond EH, Murray KJ, Schulsinger AR, Mehta MP, Curran WJ, Radiation Therapy Oncology Group
• Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.
  Journal of neuropathology and experimental neurology 2004 Fallon KB, Palmer CA, Roth KA, Nabors LB, Wang W, Carpenter M, Banerjee R, Forsyth P, Rich K, Perry A
• CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro.
  Glia 2004 Su W, Gutmann DH, Perry A, Abounader R, Laterra J, Sherman LS
• Unmasking the secrets of meningioma: a slow but rewarding journey.
  Surgical neurology 2004 Perry A
• 9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004 Rajaram V, Leuthardt EC, Singh PK, Ojemann JG, Brat DJ, Prayson RA, Perry A
• Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.
  Cancer research 2003 Bajenaru ML, Hernandez MR, Perry A, Zhu Y, Parada LF, Garbow JR, Gutmann DH
• Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features.
  Journal of neuropathology and experimental neurology 2003 Fuller CE, Schmidt RE, Roth KA, Burger PC, Scheithauer BW, Banerjee R, Trinkaus K, Lytle R, Perry A
• Status of the NF1 tumor suppressor locus in uveal melanoma.
  Archives of ophthalmology (Chicago, Ill. : 1960) 2003 Foster WJ, Fuller CE, Perry A, Harbour JW
• Identification of a third Protein 4.1 tumor suppressor, Protein 4.1R, in meningioma pathogenesis.
  Neurobiology of disease 2003 Robb VA, Li W, Gascard P, Perry A, Mohandas N, Gutmann DH
• Melanocytic colonization of a meningothelial meningioma: histopathological and ultrastructural findings with immunohistochemical and genetic correlation: case report.
  Neurosurgery 2003 Nestor SL, Perry A, Kurtkaya O, Abell-Aleff P, Rosemblat AM, Burger PC, Scheithauer BW
• Meningeal tumors of childhood and infancy. An update and literature review.
  Brain pathology (Zurich, Switzerland) 2003 Perry A, Dehner LP
• Pathology of low-grade gliomas: an update of emerging concepts.
  Neuro-oncology 2003 Perry A
• Fast magnetic resonance imaging in steady-state precession (true FISP) in the prenatal diagnosis of a congenital brain teratoma.
  Journal of computer assisted tomography 2003 Marden FA, Wippold FJ, Perry A
• Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization.
  Journal of neuropathology and experimental neurology 2003 Raghavan R, Balani J, Perry A, Margraf L, Vono MB, Cai DX, Wyatt RE, Rushing EJ, Bowers DC, Hynan LS, White CL
• High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH).
  Journal of neuropathology and experimental neurology 2002 Fuller CE, Wang H, Zhang W, Fuller GN, Perry A
• Malignant rhabdoid meningioma arising in the setting of preexisting ganglioglioma: a diagnosis supported by fluorescence in situ hybridization. Case report.
  Journal of neurosurgery 2002 Bannykh SI, Perry A, Powell HC, Hill A, Hansen LA
• Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms.
  Journal of neuropathology and experimental neurology 2002 Perry A, Kunz SN, Fuller CE, Banerjee R, Marley EF, Liapis H, Watson MA, Gutmann DH
• Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays.
  The American journal of pathology 2002 Watson MA, Gutmann DH, Peterson K, Chicoine MR, Kleinschmidt-DeMasters BK, Brown HG, Perry A
• Mantel statistics to correlate gene expression levels from microarrays with clinical covariates.
  Genetic epidemiology 2002 Shannon WD, Watson MA, Perry A, Rich K
• Treatment of metastatic rhabdoid tumor of the kidney.
  Journal of pediatric hematology/oncology 2002 Wagner L, Hill DA, Fuller C, Pedrosa M, Bhakta M, Perry A, Dome JS
• Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002 Singh PK, Gutmann DH, Fuller CE, Newsham IF, Perry A
• Comparative gene expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas.
  Cancer research 2002 Gutmann DH, Hedrick NM, Li J, Nagarajan R, Perry A, Watson MA
• Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology.
  Brain pathology (Zurich, Switzerland) 2002 Fuller CE, Perry A